img

Global Intranasal Corticosteroids Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Intranasal Corticosteroids Market Research Report 2024

Intranasal corticosteroids are the only potent and effective drugs which are used to treat various nasal complications such as nasal-polyps, nasal-rhinitis and chronic sinusitis.
According to MRAResearch’s new survey, global Intranasal Corticosteroids market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Intranasal Corticosteroids market research.
Key companies engaged in the Intranasal Corticosteroids industry include GlaxoSmithKline, Merck, Sanofi, SUMITOMO, Teva, Johnson & Johnson and AstraZeneca, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Intranasal Corticosteroids were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Intranasal Corticosteroids market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Intranasal Corticosteroids market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


GlaxoSmithKline
Merck
Sanofi
SUMITOMO
Teva
Johnson & Johnson
AstraZeneca
Segment by Type
Prescribed Drugs
OTC Drugs

Segment by Application


Hospital Pharmacies
Online Pharnacies
Retail Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Intranasal Corticosteroids report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Intranasal Corticosteroids Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Prescribed Drugs
1.2.3 OTC Drugs
1.3 Market by Application
1.3.1 Global Intranasal Corticosteroids Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital Pharmacies
1.3.3 Online Pharnacies
1.3.4 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Intranasal Corticosteroids Market Perspective (2018-2033)
2.2 Intranasal Corticosteroids Growth Trends by Region
2.2.1 Global Intranasal Corticosteroids Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Intranasal Corticosteroids Historic Market Size by Region (2018-2023)
2.2.3 Intranasal Corticosteroids Forecasted Market Size by Region (2024-2033)
2.3 Intranasal Corticosteroids Market Dynamics
2.3.1 Intranasal Corticosteroids Industry Trends
2.3.2 Intranasal Corticosteroids Market Drivers
2.3.3 Intranasal Corticosteroids Market Challenges
2.3.4 Intranasal Corticosteroids Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Intranasal Corticosteroids Players by Revenue
3.1.1 Global Top Intranasal Corticosteroids Players by Revenue (2018-2023)
3.1.2 Global Intranasal Corticosteroids Revenue Market Share by Players (2018-2023)
3.2 Global Intranasal Corticosteroids Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Intranasal Corticosteroids Revenue
3.4 Global Intranasal Corticosteroids Market Concentration Ratio
3.4.1 Global Intranasal Corticosteroids Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Intranasal Corticosteroids Revenue in 2022
3.5 Intranasal Corticosteroids Key Players Head office and Area Served
3.6 Key Players Intranasal Corticosteroids Product Solution and Service
3.7 Date of Enter into Intranasal Corticosteroids Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Intranasal Corticosteroids Breakdown Data by Type
4.1 Global Intranasal Corticosteroids Historic Market Size by Type (2018-2023)
4.2 Global Intranasal Corticosteroids Forecasted Market Size by Type (2024-2033)
5 Intranasal Corticosteroids Breakdown Data by Application
5.1 Global Intranasal Corticosteroids Historic Market Size by Application (2018-2023)
5.2 Global Intranasal Corticosteroids Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Intranasal Corticosteroids Market Size (2018-2033)
6.2 North America Intranasal Corticosteroids Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Intranasal Corticosteroids Market Size by Country (2018-2023)
6.4 North America Intranasal Corticosteroids Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Intranasal Corticosteroids Market Size (2018-2033)
7.2 Europe Intranasal Corticosteroids Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Intranasal Corticosteroids Market Size by Country (2018-2023)
7.4 Europe Intranasal Corticosteroids Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Intranasal Corticosteroids Market Size (2018-2033)
8.2 Asia-Pacific Intranasal Corticosteroids Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Intranasal Corticosteroids Market Size by Region (2018-2023)
8.4 Asia-Pacific Intranasal Corticosteroids Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Intranasal Corticosteroids Market Size (2018-2033)
9.2 Latin America Intranasal Corticosteroids Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Intranasal Corticosteroids Market Size by Country (2018-2023)
9.4 Latin America Intranasal Corticosteroids Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Intranasal Corticosteroids Market Size (2018-2033)
10.2 Middle East & Africa Intranasal Corticosteroids Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Intranasal Corticosteroids Market Size by Country (2018-2023)
10.4 Middle East & Africa Intranasal Corticosteroids Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Detail
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Intranasal Corticosteroids Introduction
11.1.4 GlaxoSmithKline Revenue in Intranasal Corticosteroids Business (2018-2023)
11.1.5 GlaxoSmithKline Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Intranasal Corticosteroids Introduction
11.2.4 Merck Revenue in Intranasal Corticosteroids Business (2018-2023)
11.2.5 Merck Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Detail
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Intranasal Corticosteroids Introduction
11.3.4 Sanofi Revenue in Intranasal Corticosteroids Business (2018-2023)
11.3.5 Sanofi Recent Development
11.4 SUMITOMO
11.4.1 SUMITOMO Company Detail
11.4.2 SUMITOMO Business Overview
11.4.3 SUMITOMO Intranasal Corticosteroids Introduction
11.4.4 SUMITOMO Revenue in Intranasal Corticosteroids Business (2018-2023)
11.4.5 SUMITOMO Recent Development
11.5 Teva
11.5.1 Teva Company Detail
11.5.2 Teva Business Overview
11.5.3 Teva Intranasal Corticosteroids Introduction
11.5.4 Teva Revenue in Intranasal Corticosteroids Business (2018-2023)
11.5.5 Teva Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Detail
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Intranasal Corticosteroids Introduction
11.6.4 Johnson & Johnson Revenue in Intranasal Corticosteroids Business (2018-2023)
11.6.5 Johnson & Johnson Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Detail
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Intranasal Corticosteroids Introduction
11.7.4 AstraZeneca Revenue in Intranasal Corticosteroids Business (2018-2023)
11.7.5 AstraZeneca Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Intranasal Corticosteroids Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Prescribed Drugs
Table 3. Key Players of OTC Drugs
Table 4. Global Intranasal Corticosteroids Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Intranasal Corticosteroids Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Intranasal Corticosteroids Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Intranasal Corticosteroids Market Share by Region (2018-2023)
Table 8. Global Intranasal Corticosteroids Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Intranasal Corticosteroids Market Share by Region (2024-2033)
Table 10. Intranasal Corticosteroids Market Trends
Table 11. Intranasal Corticosteroids Market Drivers
Table 12. Intranasal Corticosteroids Market Challenges
Table 13. Intranasal Corticosteroids Market Restraints
Table 14. Global Intranasal Corticosteroids Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Intranasal Corticosteroids Market Share by Players (2018-2023)
Table 16. Global Top Intranasal Corticosteroids Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intranasal Corticosteroids as of 2022)
Table 17. Ranking of Global Top Intranasal Corticosteroids Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Intranasal Corticosteroids Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Intranasal Corticosteroids Product Solution and Service
Table 21. Date of Enter into Intranasal Corticosteroids Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Intranasal Corticosteroids Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Intranasal Corticosteroids Revenue Market Share by Type (2018-2023)
Table 25. Global Intranasal Corticosteroids Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Intranasal Corticosteroids Revenue Market Share by Type (2024-2033)
Table 27. Global Intranasal Corticosteroids Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Intranasal Corticosteroids Revenue Market Share by Application (2018-2023)
Table 29. Global Intranasal Corticosteroids Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Intranasal Corticosteroids Revenue Market Share by Application (2024-2033)
Table 31. North America Intranasal Corticosteroids Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Intranasal Corticosteroids Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Intranasal Corticosteroids Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Intranasal Corticosteroids Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Intranasal Corticosteroids Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Intranasal Corticosteroids Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Intranasal Corticosteroids Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Intranasal Corticosteroids Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Intranasal Corticosteroids Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Intranasal Corticosteroids Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Intranasal Corticosteroids Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Intranasal Corticosteroids Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Intranasal Corticosteroids Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Intranasal Corticosteroids Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Intranasal Corticosteroids Market Size by Country (2024-2033) & (US$ Million)
Table 46. GlaxoSmithKline Company Detail
Table 47. GlaxoSmithKline Business Overview
Table 48. GlaxoSmithKline Intranasal Corticosteroids Product
Table 49. GlaxoSmithKline Revenue in Intranasal Corticosteroids Business (2018-2023) & (US$ Million)
Table 50. GlaxoSmithKline Recent Development
Table 51. Merck Company Detail
Table 52. Merck Business Overview
Table 53. Merck Intranasal Corticosteroids Product
Table 54. Merck Revenue in Intranasal Corticosteroids Business (2018-2023) & (US$ Million)
Table 55. Merck Recent Development
Table 56. Sanofi Company Detail
Table 57. Sanofi Business Overview
Table 58. Sanofi Intranasal Corticosteroids Product
Table 59. Sanofi Revenue in Intranasal Corticosteroids Business (2018-2023) & (US$ Million)
Table 60. Sanofi Recent Development
Table 61. SUMITOMO Company Detail
Table 62. SUMITOMO Business Overview
Table 63. SUMITOMO Intranasal Corticosteroids Product
Table 64. SUMITOMO Revenue in Intranasal Corticosteroids Business (2018-2023) & (US$ Million)
Table 65. SUMITOMO Recent Development
Table 66. Teva Company Detail
Table 67. Teva Business Overview
Table 68. Teva Intranasal Corticosteroids Product
Table 69. Teva Revenue in Intranasal Corticosteroids Business (2018-2023) & (US$ Million)
Table 70. Teva Recent Development
Table 71. Johnson & Johnson Company Detail
Table 72. Johnson & Johnson Business Overview
Table 73. Johnson & Johnson Intranasal Corticosteroids Product
Table 74. Johnson & Johnson Revenue in Intranasal Corticosteroids Business (2018-2023) & (US$ Million)
Table 75. Johnson & Johnson Recent Development
Table 76. AstraZeneca Company Detail
Table 77. AstraZeneca Business Overview
Table 78. AstraZeneca Intranasal Corticosteroids Product
Table 79. AstraZeneca Revenue in Intranasal Corticosteroids Business (2018-2023) & (US$ Million)
Table 80. AstraZeneca Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Intranasal Corticosteroids Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Intranasal Corticosteroids Market Share by Type: 2022 VS 2033
Figure 3. Prescribed Drugs Features
Figure 4. OTC Drugs Features
Figure 5. Global Intranasal Corticosteroids Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Intranasal Corticosteroids Market Share by Application: 2022 VS 2033
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Online Pharnacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Intranasal Corticosteroids Report Years Considered
Figure 11. Global Intranasal Corticosteroids Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Intranasal Corticosteroids Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Intranasal Corticosteroids Market Share by Region: 2022 VS 2033
Figure 14. Global Intranasal Corticosteroids Market Share by Players in 2022
Figure 15. Global Top Intranasal Corticosteroids Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intranasal Corticosteroids as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Intranasal Corticosteroids Revenue in 2022
Figure 17. North America Intranasal Corticosteroids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Intranasal Corticosteroids Market Share by Country (2018-2033)
Figure 19. United States Intranasal Corticosteroids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Intranasal Corticosteroids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Intranasal Corticosteroids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Intranasal Corticosteroids Market Share by Country (2018-2033)
Figure 23. Germany Intranasal Corticosteroids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Intranasal Corticosteroids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Intranasal Corticosteroids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Intranasal Corticosteroids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Intranasal Corticosteroids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Intranasal Corticosteroids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Intranasal Corticosteroids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Intranasal Corticosteroids Market Share by Region (2018-2033)
Figure 31. China Intranasal Corticosteroids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Intranasal Corticosteroids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Intranasal Corticosteroids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Intranasal Corticosteroids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Intranasal Corticosteroids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Intranasal Corticosteroids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Intranasal Corticosteroids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Intranasal Corticosteroids Market Share by Country (2018-2033)
Figure 39. Mexico Intranasal Corticosteroids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Intranasal Corticosteroids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Intranasal Corticosteroids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Intranasal Corticosteroids Market Share by Country (2018-2033)
Figure 43. Turkey Intranasal Corticosteroids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Intranasal Corticosteroids Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. GlaxoSmithKline Revenue Growth Rate in Intranasal Corticosteroids Business (2018-2023)
Figure 46. Merck Revenue Growth Rate in Intranasal Corticosteroids Business (2018-2023)
Figure 47. Sanofi Revenue Growth Rate in Intranasal Corticosteroids Business (2018-2023)
Figure 48. SUMITOMO Revenue Growth Rate in Intranasal Corticosteroids Business (2018-2023)
Figure 49. Teva Revenue Growth Rate in Intranasal Corticosteroids Business (2018-2023)
Figure 50. Johnson & Johnson Revenue Growth Rate in Intranasal Corticosteroids Business (2018-2023)
Figure 51. AstraZeneca Revenue Growth Rate in Intranasal Corticosteroids Business (2018-2023)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed